Type 2 & other diabetes

Optimal Dose and Type of Physical Activity to Improve Glycemic Control in People Diagnosed With Type 2 Diabetes: A Systematic Review and Meta-analysis

Diabetes CarePublished Systematic review and meta-analysis

Authors' conclusion

The result of this meta-analysis provide key information about the optimal weekly dose of physical activity for people with diabetes with consideration of baseline HbA1c level, and the effectiveness of different types of active interventions. These results enable clinicians to prescribe tailored physical activity programs for this population.

Study context

Population
Individuals with T2D in trials of any type of physical activity as intervention
Participants
6,718 individuals126 studies
Comparison
Physical activity, dose-response for HbA1c
Outcome
Dose-response relationship between physical activity and HbA1c (%)
Methodological detailsBayesian random-effects meta-analyses, dose-response, Time required to achieve HbA1c reductions could not be estimated (heterogeneity of intervention duration and protocols, interpersonal variability)
  • Bayesian random-effects meta-analyses
  • Dose-response
  • Time required to achieve HbA1c reductions could not be estimated (heterogeneity of intervention duration and protocols, interpersonal variability)

Pooled result

As reported in the abstract

HbA1c change at optimal physical activity dose of 1,100 MET min/week
Optimal physical activity dose
1,100 MET min/week
HbA1c reduction, severe uncontrolled diabetes
−1.02% to −0.66%
HbA1c reduction, uncontrolled diabetes
−0.64% to −0.49%
HbA1c reduction, controlled diabetes
−0.47% to −0.40%
HbA1c reduction, prediabetes
−0.38% to −0.24%

Original publication

Optimal Dose and Type of Physical Activity to Improve Glycemic Control in People Diagnosed With Type 2 Diabetes: A Systematic Review and Meta-analysis. Diabetes Care. Published 19 January 2024. doi:10.2337/dc23-0800

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.